PROGNOSTIC VALUE OF INTRACELLULAR ADHESION MOLECULES IN HEMOLYTIC-UREMIC SYNDROME
- Authors: Moskalets O.V.1, Pankratenko T.E.1
-
Affiliations:
- Moscow Regional Research and Clinical Institute named after M. F. Vladimirskij
- Issue: Vol 22, No 2-1 (2019)
- Pages: 426-428
- Section: ORIGINAL ARTICLES
- URL: https://journals.rcsi.science/1028-7221/article/view/120239
- DOI: https://doi.org/10.31857/S102872210006919-5
- ID: 120239
Cite item
Full Text
Abstract
The article presents the results of a study assessing the diagnostic and prognostic significance of determining the content of soluble intercellular adhesion molecules in children with typical and atypical hemolytic-uremic syndrome.
About the authors
O. V. Moskalets
Moscow Regional Research and Clinical Institute named after M. F. Vladimirskij
Author for correspondence.
Email: 6816000@mail.ru
PhD, Leading Researcher, Research Laboratory,
Moscow
Russian FederationT. E. Pankratenko
Moscow Regional Research and Clinical Institute named after M. F. Vladimirskij
PhD, Assistant Professor of Department of Transplantology, Nephrology and Artificial Organs, Faculty of Advanced Medical Studies,
Moscow
Russian FederationReferences
- Talarico V., Aloe M., Monzani A., Miniero R., Bona G. Hemolytic uremic syndrome in children. Minerva Pediatr.2016; 68(6), 441–445.
- Keir L. S., Marks S. D., Kim J. J. Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies. Drug Des Devel Ther. 2012;6, 195–208.
- Loirat C., Frémeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis. 2011; 6, 60–66.
- Москалец О. В. Молекулы клеточной адгезии ICAM-1 и VCAM-1 при инфекционной патологии. Тихоокеанский медицинский журнал. 2018, 2, 21–25.
- Carter S., Hewitt I., Kausman J. Long-term remission with eculizumab in atypical haemolytic uraemic syndrome. Nephrology(Cariton). 2017;22 (Suppl.1),7–10.
Supplementary files
